ISPOR International Panel Calls for Consensus on Medication Adherence Measures

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Expert Panel Publishes Good Practices Recommendations for the Selection, Development, and Modification of Health-Related Performance Outcome Assessments

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of an ISPOR Good Practices Report providing recommendations on performance outcome (PerfO) assessments.

Global Expert Panel Publishes New Guidance on Measurement Comparability Between Methods of Patient Data Collection Recommending Move Away from Additional Testing

Value in Health, the official journal of ISPOR, announced today the publication of an ISPOR Good Practices Report providing recommendations for assessing the need to demonstrate comparability among ways to collect patient responses.

Global Expert Panel Publishes New Guidance on Designing, Conducting, and Analyzing Quantitative Benefit-Risk Assessment

Value in Health, the official journal of ISPOR, announced the publication of new good practice guidelines for the design, conduct, analysis, and communication of quantitative benefit-risk assessments (qBRA) to support regulatory decision making of medical products.

ISPOR Announces New CEO

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its Board of Directors has appointed Rob Abbott as the Society’s new CEO and executive director after an extensive search process. Mr Abbott will assume the role of ISPOR’s CEO on March 13, 2023, succeeding Nancy S. Berg who is retiring.

Global Experts Introduce Strategic Action Plan to Accelerate Patient Access to Next-Generation DNA Sequencing in Oncology

Value & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology.”

ISPOR-FDA Summit 2020 Will Focus on the Use of Patient-Preference Information in Medical Devices

ISPOR—the professional society for health economics and outcomes research, announced that it will be holding a joint ISPOR-FDA Summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” on March 31, 2020 in Silver Spring, MD, USA.

ISPOR Publishes 2020 Top 10 Health Economics and Outcomes Research (HEOR) Trends Report

ISPOR—the professional society for health economics and outcomes research (HEOR), announced the publication of its 2020 Top 10 HEOR Trends report. In the report, the Society has identified the top 10 HEOR trends that will shape the field and influence healthcare over 2020 and the near future.